MedTrace Logo

Evaluation of the Clinical Performance of the Quantra System With the QStat Cartridge

NCT03912545 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 30

Last updated 2019-10-01

No results posted yet for this study

Summary

This pilot study will evaluate the performance of the Quantra System comprised of the Quantra Hemostasis Analyzer with the QStat Cartridge in trauma patients or patients with OB hemorrhage.

Conditions

  • Blood Loss Massive
  • Trauma
  • Hemorrhage, Postpartum

Interventions

DIAGNOSTIC_TEST

Quantra System

Diagnostic device to monitor coagulation properties of a whole blood sample at the point-of-care.

Sponsors & Collaborators

  • HemoSonics LLC

    lead INDUSTRY

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-03-04
Primary Completion
2019-07-11
Completion
2019-07-11
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03912545 on ClinicalTrials.gov